Advertisement
Screener

Avantor, Inc. (AVTR) Revenue

Avantor, Inc. Revenue

Avantor, Inc. (AVTR) reported Revenue of $1.58 billion for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.

Financial Statements › Income Statement

us-gaap:Revenues · last filed 2026-04-29

  • Avantor, Inc. revenues for the quarter ending 2026-03-31 was $1.58B, a 0.00% change year-over-year.
  • Avantor, Inc. revenues for the quarter ending 2025-12-31 was $1.66B, a 1.36% decline year-over-year.
  • Avantor, Inc. revenues for the quarter ending 2025-09-30 was $1.62B, a 5.28% decline year-over-year.
  • Avantor, Inc. revenues for the quarter ending 2025-06-30 was $1.68B, a 1.14% decline year-over-year.
  • Avantor, Inc. revenues for fiscal 2025 was $6.55B, a 3.41% decline from fiscal 2024.
  • Avantor, Inc. revenues for fiscal 2024 was $6.78B, a 2.64% decline from fiscal 2023.
  • Avantor, Inc. revenues for fiscal 2023 was $6.97B, a 7.26% decline from fiscal 2022.
  • Avantor, Inc. revenues for fiscal 2022 was $7.51B, a 1.71% increase from fiscal 2021.
Period endRevenues 3 monthRevenues 6 monthRevenues 9 monthRevenues 12 month
2026-03-31$1.58B
10-Q · filed 2026-04-29
$3.25B
derived: sum of 2 quarters · filed 2026-04-29
$4.87B
derived: sum of 3 quarters · filed 2026-04-29
$6.55B
derived: sum of 4 quarters · filed 2026-04-29
2025-12-31$1.66B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$3.29B
derived: sum of 2 quarters · filed 2026-02-11
$4.97B
derived: sum of 3 quarters · filed 2026-02-11
$6.55B
10-K · filed 2026-02-11
2025-09-30$1.62B
10-Q · filed 2025-10-29
$3.31B
derived: sum of 2 quarters · filed 2025-10-29
$4.89B
10-Q · filed 2025-10-29
$6.58B
derived: sum of 4 quarters · filed 2026-04-29
2025-06-30$1.68B
10-Q · filed 2025-08-01
$3.26B
10-Q · filed 2025-08-01
$4.95B
derived: sum of 3 quarters · filed 2026-04-29
$6.67B
derived: sum of 4 quarters · filed 2026-04-29
2025-03-31$1.58B
10-Q · filed 2026-04-29
$3.27B
derived: sum of 2 quarters · filed 2026-04-29
$4.98B
derived: sum of 3 quarters · filed 2026-04-29
$6.69B
derived: sum of 4 quarters · filed 2026-04-29
2024-12-31$1.69B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$3.40B
derived: sum of 2 quarters · filed 2026-02-11
$5.10B
derived: sum of 3 quarters · filed 2026-02-11
$6.78B
10-K · filed 2026-02-11
2024-09-30$1.71B
10-Q · filed 2025-10-29
$3.42B
derived: sum of 2 quarters · filed 2025-10-29
$5.10B
10-Q · filed 2025-10-29
$6.82B
derived: sum of 4 quarters · filed 2026-02-11
2024-06-30$1.70B
10-Q · filed 2025-08-01
$3.38B
10-Q · filed 2025-08-01
$5.11B
derived: sum of 3 quarters · filed 2026-02-11
$6.83B
derived: sum of 4 quarters · filed 2026-02-11
2024-03-31$1.68B
10-Q · filed 2025-04-25
$3.40B
derived: sum of 2 quarters · filed 2026-02-11
$5.12B
derived: sum of 3 quarters · filed 2026-02-11
$6.87B
derived: sum of 4 quarters · filed 2026-02-11
2023-12-31$1.72B
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11
$3.44B
derived: sum of 2 quarters · filed 2026-02-11
$5.19B
derived: sum of 3 quarters · filed 2026-02-11
$6.97B
10-K · filed 2026-02-11
2023-09-30$1.72B
10-Q · filed 2024-10-25
$3.46B
derived: sum of 2 quarters · filed 2024-10-25
$5.24B
10-Q · filed 2024-10-25
$7.04B
derived: sum of 4 quarters · filed 2025-02-07
2023-06-30$1.74B
10-Q · filed 2024-07-26
$3.52B
10-Q · filed 2024-07-26
$5.32B
derived: sum of 3 quarters · filed 2025-02-07
$7.18B
derived: sum of 4 quarters · filed 2025-02-07
2023-03-31$1.78B
10-Q · filed 2024-04-26
$3.58B
derived: sum of 2 quarters · filed 2025-02-07
$5.43B
derived: sum of 3 quarters · filed 2025-02-07
$7.34B
derived: sum of 4 quarters · filed 2025-02-07
2022-12-31$1.79B
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07
$3.65B
derived: sum of 2 quarters · filed 2025-02-07
$5.56B
derived: sum of 3 quarters · filed 2025-02-07
$7.51B
10-K · filed 2025-02-07
2022-09-30$1.86B
10-Q · filed 2023-10-27
$3.77B
derived: sum of 2 quarters · filed 2023-10-27
$5.72B
10-Q · filed 2023-10-27
$7.63B
derived: sum of 4 quarters · filed 2024-02-14
2022-06-30$1.91B
10-Q · filed 2023-07-28
$3.86B
10-Q · filed 2023-07-28
$5.77B
derived: sum of 3 quarters · filed 2024-02-14
$7.60B
derived: sum of 4 quarters · filed 2024-02-14
2022-03-31$1.95B
10-Q · filed 2023-04-28
$3.86B
derived: sum of 2 quarters · filed 2024-02-14
$5.69B
derived: sum of 3 quarters · filed 2024-02-14
$7.55B
derived: sum of 4 quarters · filed 2024-02-14
2021-12-31$1.91B
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
$3.74B
derived: sum of 2 quarters · filed 2024-02-14
$5.60B
derived: sum of 3 quarters · filed 2024-02-14
$7.39B
10-K · filed 2024-02-14
2021-09-30$1.83B
10-Q · filed 2022-10-28
$3.69B
derived: sum of 2 quarters · filed 2022-10-28
$5.48B
10-Q · filed 2022-10-28
$7.27B
derived: sum of 4 quarters · filed 2022-10-28
2021-06-30$1.86B
10-Q · filed 2022-07-29
$3.64B
10-Q · filed 2022-07-29
$5.44B
derived: sum of 3 quarters · filed 2022-07-29
$7.04B
derived: sum of 4 quarters · filed 2022-07-29
2021-03-31$1.79B
10-Q · filed 2022-04-29
$3.58B
derived: sum of 2 quarters · filed 2022-04-29
$5.18B
derived: sum of 3 quarters · filed 2022-04-29
$6.66B
derived: sum of 4 quarters · filed 2022-04-29
2020-12-31$1.79B
10-K · filed 2021-02-16
$3.40B
derived: sum of 2 quarters · filed 2021-10-29
$4.87B
derived: sum of 3 quarters · filed 2021-10-29
$6.39B
10-K · filed 2023-02-14
2020-09-30$1.60B
10-Q · filed 2021-10-29
$3.08B
derived: sum of 2 quarters · filed 2021-10-29
$4.60B
10-Q · filed 2021-10-29
$6.13B
derived: sum of 4 quarters · filed 2021-10-29
2020-06-30$1.48B
10-Q · filed 2021-07-30
$3.00B
10-Q · filed 2021-07-30
$4.52B
derived: sum of 3 quarters · filed 2021-07-30
$6.03B
derived: sum of 4 quarters · filed 2021-07-30
2020-03-31$1.52B
10-Q · filed 2021-04-28
$3.04B
derived: sum of 2 quarters · filed 2021-04-28
$4.55B
derived: sum of 3 quarters · filed 2021-04-28
$6.08B
derived: sum of 4 quarters · filed 2021-04-28
2019-12-31$1.52B
10-K · filed 2021-02-16
$3.03B
derived: sum of 2 quarters · filed 2021-02-16
$4.56B
derived: sum of 3 quarters · filed 2021-02-16
$6.04B
10-K · filed 2022-02-11
2019-09-30$1.50B
10-K · filed 2021-02-16
$3.04B
derived: sum of 2 quarters · filed 2021-02-16
$4.52B
10-Q · filed 2020-10-27
$5.99B
derived: sum of 4 quarters · filed 2021-02-16
2019-06-30$1.53B
10-K · filed 2021-02-16
$3.01B
10-Q · filed 2020-07-29
$4.49B
derived: sum of 3 quarters · filed 2021-02-16
$5.98B
derived: sum of 4 quarters · filed 2021-02-16
2019-03-31$1.48B
10-K · filed 2021-02-16
$2.95B
derived: sum of 2 quarters · filed 2021-02-16
$4.45B
derived: sum of 3 quarters · filed 2021-02-16
$5.93B
derived: sum of 4 quarters · filed 2021-02-16
2018-12-31$1.47B
10-K · filed 2020-02-14
$2.97B
derived: sum of 2 quarters · filed 2020-02-14
$4.45B
derived: sum of 3 quarters · filed 2020-02-14
$5.86B
10-K · filed 2021-02-16
2018-09-30$1.49B
10-K · filed 2020-02-14
$2.97B
derived: sum of 2 quarters · filed 2020-02-14
$4.39B
10-Q · filed 2019-11-05
2018-06-30$1.48B
10-K · filed 2020-02-14
$2.90B
10-Q · filed 2019-08-06
2018-03-31$1.42B
10-K · filed 2020-02-14
2017-12-31$1.25B
10-K · filed 2020-02-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
BRUKER CORP (BRKR)United States$9.706B-128.75
REVVITY, INC. (RVTY)United States$16.814B53.44
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34